Search
Search
Login
  • Register
Action Pulmonary Fibrosis (APF)
  • Information & Support
    keyboard_arrow_down
    • For people who are:
    • stethoscopeNewly Diagnosed
    • manLiving with PF
    • front_handCaring for someone
    • Information
    • chevron_forwardCoronavirus Hub
    • chevron_forwardWhat is Pulmonary Fibrosis?
    • chevron_forwardTypes of Pulmonary Fibrosis
    • chevron_forwardTreatments
    • chevron_forwardBenefits
    • chevron_forwardOxygen
    • chevron_forwardHave I got PF?
    • chevron_forwardInformation resources
    • chevron_forwardWebinars
    • Support
    • chevron_forwardSupport line
    • chevron_forwardSupport groups
    • chevron_forwardSpecialist ILD centres
    • chevron_forwardPF Together Magazine
    • Personal stories
  • Get Involved
    keyboard_arrow_down
    • Fundraise
    • chevron_forwardPF Awareness Month 2026
    • chevron_forwardFundraise for us
    • Improve PF Care
    • Shop
    • Donate
    • chevron_forwardDonate today
    • chevron_forwardGive in memory
    • chevron_forwardLeave a gift in your will
    • chevron_forwardWeekly lottery
  • Healthcare Professionals
  • Research
    keyboard_arrow_down
    • Take part in research
    • chevron_forwardWhat is research?
    • chevron_forwardFind a study
    • chevron_forwardFAQs
    • chevron_forwardResearch stories
    • Our research
    • chevron_forwardAPF research
    • chevron_forwardResearch priorities
    • chevron_forwardSupport for researchers
    • chevron_forwardDonate to research
    • Research news
  • About Us
    keyboard_arrow_down
    • chevron_forwardAbout our charity
    • chevron_forwardNews
    • chevron_forwardOur strategy
    • chevron_forwardSurveys and reports
    • chevron_forwardPeople
    • chevron_forwardJobs
    • chevron_forwardAnnual Reports
    • chevron_forwardContact us
search Donate
Sign up to the APF Newsletter to keep informed about our latest workarrow_forward
Information

Nintedanib and Pirfenidone - antifibrotics for pulmonary fibrosis

Your pulmonary fibrosis treatment will depend on your condition. Although there is no cure for pulmonary fibrosis at present, recent studies suggest that antifibrotic medications can reduce the rate of scarring.

What are antifibrotics?

Antifibrotic medications like nintedanib and pirfenidone can slow down the build-up of scar tissue or fibrosis in the lungs and can be used to treat pulmonary fibrosis. These treatments may reduce the rate that your lung fibrosis progresses but they don’t stop the lung scarring completely or get rid of any scar tissue that has already formed.

You can also find out about other treatments for hypersensitivity pneumonitis or autoimmune diseases, such as rheumatoid arthritis and systemic sclerosis.

Male nurse explaining with hands

Download nintedanib information booklet

View online or order

Download pirfenidone information booklet

View online or order

I struggled on one antifibrotic so was started on the other – and now I can say I don’t know I’m taking it

Privately purchasing antifibrotic medication

Private purchase

Some people face long waiting times to be diagnosed and prescribed antifibrotics by a specialist ILD team. This can be an anxious time, and some people consider purchasing antifibrotic treatments privately, before a formal diagnosis and treatment plan are agreed upon with an ILD team.

At APF, we do not recommend the private purchase of antifibrotic treatments. They can have serious side effects and require regular monitoring by an ILD specialist team. If you privately purchase antifibrotics, you won’t have access to regular specialist monitoring and care, and may be putting your health at further risk.

We recognise that being on a waiting list can be distressing. If you have questions or need someone to talk to, our support line team is here for you.

You can also contact your local Patient Advice Liaison Service (PALS). PALS can support you with questions or concerns related to your care and help you get the most from your NHS services.

Reducing wait times

We are determined to improve the time it takes to access antifibrotic medications. #OneVoiceILD is our movement to bring together people affected by pulmonary fibrosis, politicians and pulmonary fibrosis experts across the UK. #OneVoiceILD is working to improve pulmonary fibrosis care, including reducing the wait to start treatment. Get in touch with us at OVILD@actionpf.org to find out how you can support our work.

Other medications

You may also be offered other treatment – such as medications to help manage a cough or breathlessness, and over-the-counter medicines and advice to manage acid reflux.

Our website and resources provide general information only. We cannot provide medical advice, treatment or prescriptions, nor can we assess/decide what services or clinicians you should be referred to. Support with these matters will need to be provided by your existing healthcare professional teams.

APF is not responsible for any errors or omissions or for any loss or damage suffered by users resulting from the information published on our website or in our resources.

Tab ID:187
APF

01733 839642

info@actionpf.org

call

Support line
01223 785725

article

Sign up for
our newsletter

Contact About us Jobs News Donate

England & Wales Charity Registration Number: 1152399, Scotland Charity Registration Number: SCO50992

Privacy Policy Cookie Preferences
AMRC Logo
Funding Regulator
Copyright 2026 by APF
Terms Of Use | Privacy Statement